Asian Journal Of Social Pharmacy

Abstract: Objective To help investors assess and control the costs of new drug development and reduce the risks of new drug development projects. Methods Cost analysis and financial forecasting were carried out with the integrated approach of earned value management. According to the principle of earned value management deviation analysis, the basic process of the new drug research and development project was combined with the hypothesis method from the research of Tufts Drug Development Research Center. Results and Conclusion If the project progress check was carried out in the clinical trial, the project costs were found overspent, the efficiency was low, the project progress was faster, and the resource investment was ahead. It is recommended that the adjustment should be made to reduce the input of resources, and increase the efficient key personnel to take the place of some less efficient staff.

Key words: new drug research and development, earned value management, cost analysis